50 results
Page 2 of 3
8-K
EX-99.5
ln0migwdtbj8
14 Mar 22
Interim results demonstrate approximately 70% decreased risk of death for participants who entered the RESCUE-ALS long-term open label extension
7:02am
8-K
EX-10.3
gcjs tidx36n81fsxln5
2 Feb 22
Clene Announces New Chief Financial Officer Morgan Brown
12:00am
8-K
EX-10.1
idnaka n9
2 Feb 22
Clene Announces New Chief Financial Officer Morgan Brown
12:00am
8-K
EX-10.4
owapvbqq6u72u3
2 Feb 22
Clene Announces New Chief Financial Officer Morgan Brown
12:00am
424B3
rgy39a9mq78j4n3v8
10 Nov 21
Prospectus supplement
4:02pm
424B3
daqqt
10 Nov 21
Prospectus supplement
4:01pm
8-K
EX-10.1
tlqpbzja15t30kvsd
11 Aug 21
Entry into a Material Definitive Agreement
7:05am
8-K
EX-10.2
k7kjub5mo46s
11 Aug 21
Entry into a Material Definitive Agreement
7:05am
424B3
fg99pnyjzqdu90m0
2 Aug 21
Prospectus supplement
5:03pm
424B3
70l2ruba 371
24 May 21
Prospectus supplement
4:38pm
8-K
EX-10.1
vm32ly327uxredj69
24 May 21
Entry into a Material Definitive Agreement
4:29pm
424B3
f2cr0mq wzw
21 Apr 21
Prospectus supplement
6:04am
10-K
qbn8injr
29 Mar 21
Annual report
12:00am
S-1
ybrsngf7zr9hvzm4w
17 Feb 21
IPO registration
12:00am
8-K
EX-10.4
xhvic50ydocbhg6
5 Jan 21
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update
5:18pm
424B3
n05zul1 r71bs6
18 Dec 20
Prospectus supplement
2:24pm